Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04371120 · ClinicalTrials.gov registry record
Brain Injury Self-Efficacy Scale Validation
A clinical trial, sponsored by Rehabilitation Hospital of Indiana.
- Terminated
- Registry status
- 150
- Enrollment target
NCT04371120 is a clinical trial that was terminated before completion, run by Rehabilitation Hospital of Indiana. The registered enrollment target is 150 participants.
The verdict
NCT04371120 was terminated before completion, sponsored by Rehabilitation Hospital of Indiana.
- TERMINATED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the Brain Injury Self-Efficacy Scale as a measure of self-efficacy in brain injury by comparing it with other measures of self-efficacy, the GSE, and PROMIS self-efficacy.
Interventions
- DIAGNOSTIC_TEST BICS Q
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04371120
The ClinicalTrials.gov registry entry for NCT04371120 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rehabilitation Hospital of Indiana, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BICS Q is the first listed.
NCT04371120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04371120 about?
NCT04371120 is a clinical study titled "Brain Injury Self-Efficacy Scale Validation". The purpose of this study is to validate the Brain Injury Self-Efficacy Scale as a measure of self-efficacy in brain injury by comparing it with other measures of self-efficacy, the GSE, and PROMIS self-efficacy.
What is the current status of trial NCT04371120?
This trial is currently terminated. The enrollment target is 150 participants. The study started on 2019-04-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT04371120?
The interventions under investigation include: BICS Q (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04371120?
This trial is sponsored by Rehabilitation Hospital of Indiana, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.